MedPath

SERB SAS

🇫🇷France
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

EMA:2
CANADA:1

Drug Approvals

Voraxaze

Authorization Status
Authorised
Approval Date
Jan 11, 2022
EMA

Xermelo

Authorization Status
Authorised
Approval Date
Sep 17, 2017
EMA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.